Cargando…
CB1 receptor blockade counters age‐induced insulin resistance and metabolic dysfunction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135075/ https://www.ncbi.nlm.nih.gov/pubmed/34014030 http://dx.doi.org/10.1111/acel.13378 |
Ejemplares similares
-
CB1 receptor blockade counters age‐induced insulin resistance and metabolic dysfunction
por: Lipina, Christopher, et al.
Publicado: (2016) -
Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”
por: Wang, Yong, et al.
Publicado: (2019) -
Corrigendum to “Oral Adverse Reactions Caused by Over-the-Counter Oral Agents”
por: Boras, Vanja Vucicevic, et al.
Publicado: (2019) -
Early 5‐HT(6)
receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
por: Berthoux, Coralie, et al.
Publicado: (2022) -
Corrigendum: Author's Name and Affiliation Correction. The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women
por: AminiLari, Zeinab, et al.
Publicado: (2017)